Drug Safety. hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Eighty-Ninth Congress, first session, on July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965. Part 4 :

Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill.

Bibliographic Details
Corporate Authors:	United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 1965.
Series:	U.S. Congressional Hearings.
Subjects:	United States. > Food and Drug Administration. Drugs > Testing > Law and legislation > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill.
Item Description:	Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC. Electronic resource.
Physical Description:	1 online resource.
Format:	System requirements: PDF reader software.